ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,815Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 393

$703K Total Retail Price of All Prescriptions

Rank: 24 out of 393

1,670 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,670 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 1,670 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,907 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 980 891 1 2
SIMVASTATIN 902 839 2 1
OMEPRAZOLE 825 780 3 6
HYDROCODONE-ACETAMINOPHEN 713 607 S3 4 5
LEVOTHYROXINE SODIUM 683 619 5 3
AMLODIPINE BESYLATE 637 601 6 4
ATENOLOL 390 347 7 13
ZOLPIDEM TARTRATE 371 316 8 11
METFORMIN HCL 349 303 9 7
HYDROCHLOROTHIAZIDE 342 327 10 10
WARFARIN SODIUM 288 278 11 17
GABAPENTIN 272 215 12 15
LOSARTAN POTASSIUM 270 254 13 12
TAMSULOSIN HCL 237 223 14 25
FUROSEMIDE 234 219 15 8
METOPROLOL TARTRATE 225 220 16 9
LOVASTATIN 213 213 17 14
ALENDRONATE SODIUM 198 184 18 16
CITALOPRAM HBR 198 193 18 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 196 175 20 24
VENTOLIN HFA 178 148 21 42
GLIMEPIRIDE 165 125 22 39
CARVEDILOL 162 154 23 21
IBUPROFEN 162 112 23 55
PRAVASTATIN SODIUM 162 147 23 18
TRAMADOL HCL 159 134 26 30
TIZANIDINE HCL 157 130 27 97
POTASSIUM CHLORIDE 152 133 28 20
METOPROLOL SUCCINATE 147 139 29 22
SPIRIVA 145 141 30 41
FLUTICASONE PROPIONATE 141 130 31 27
CIPROFLOXACIN HCL 136 122 32 57
CLOPIDOGREL 135 116 33 33
FENOFIBRATE 126 106 34 43
ALLOPURINOL 115 108 35 26
FINASTERIDE 108 104 36 60
METFORMIN HCL ER 107 102 37 63
PLAVIX 106 94 38 51
LOSARTAN-HYDROCHLOROTHIAZIDE 99 97 39 31
DONEPEZIL HCL 98 97 40 34
TRIAMTERENE-HCTZ 98 86 40 49
POLYETHYLENE GLYCOL 3350 94 77 42 99
RANITIDINE HCL 93 76 43 29
SERTRALINE HCL 92 72 44 28
GLIPIZIDE 92 81 44 32
LANTUS SOLOSTAR 87 61 46 74
OXYCODONE HCL-ACETAMINOPHEN 87 52 S2 46 54
NIFEDIPINE ER 87 79 46 91
FLUOXETINE HCL 85 59 49 37
GLIPIZIDE ER 84 82 50 76
ATORVASTATIN CALCIUM 83 69 51 19
TRAZODONE HCL 83 62 51 47
AZITHROMYCIN 83 74 51 35
TERAZOSIN HCL 79 79 54 38
OXYCODONE HCL 75 52 S2 55 36
DILTIAZEM 24HR ER 65 63 56 129
GLYBURIDE 65 61 R 56 46
DIGOXIN 61 57 58 66
HYDRALAZINE HCL 61 61 58 64
ACTOS 60 56 60 78
LANTUS 59 51 61 73
ISOSORBIDE MONONITRATE ER 59 57 61 67
OXYCODONE-ACETAMINOPHEN 58 51 S2 63 71
SUMATRIPTAN SUCCINATE 55 31 64 227
QVAR 54 54 65 101
MORPHINE SULFATE ER 53 20 S2 66 48
CARISOPRODOL 51 29 R 67 45
GEMFIBROZIL 51 36 67 62
PAROXETINE HCL 51 50 67 61
BENICAR HCT 50 43 70 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.